Thermosensitive hydrogels deliver bioactive protein to the vaginal wall

Meadow M. Good, T. Ignacio Montoya, Haolin Shi, Jun Zhou, Yi Hui Huang, Liping Tang, Jesus F. Acevedo, R. Ann Word

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the ½ life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.

Original languageEnglish (US)
Article numbere0186268
JournalPLoS One
Volume12
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Hydrogels
Pelvic Organ Prolapse
hydrocolloids
gelatinase B
Matrix Metalloproteinases
Proteins
proteins
Tissue
elastin
ethylene glycol
ligaments
pathophysiology
natural history
extracellular matrix
Military electronic countermeasures
fibroblasts
collagen
Ethylene Glycol
Elastin
Hydrogel

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Good, M. M., Montoya, T. I., Shi, H., Zhou, J., Huang, Y. H., Tang, L., ... Word, R. A. (2017). Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. PLoS One, 12(10), [e0186268]. https://doi.org/10.1371/journal.pone.0186268

Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. / Good, Meadow M.; Montoya, T. Ignacio; Shi, Haolin; Zhou, Jun; Huang, Yi Hui; Tang, Liping; Acevedo, Jesus F.; Word, R. Ann.

In: PLoS One, Vol. 12, No. 10, e0186268, 01.10.2017.

Research output: Contribution to journalArticle

Good, MM, Montoya, TI, Shi, H, Zhou, J, Huang, YH, Tang, L, Acevedo, JF & Word, RA 2017, 'Thermosensitive hydrogels deliver bioactive protein to the vaginal wall', PLoS One, vol. 12, no. 10, e0186268. https://doi.org/10.1371/journal.pone.0186268
Good MM, Montoya TI, Shi H, Zhou J, Huang YH, Tang L et al. Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. PLoS One. 2017 Oct 1;12(10). e0186268. https://doi.org/10.1371/journal.pone.0186268
Good, Meadow M. ; Montoya, T. Ignacio ; Shi, Haolin ; Zhou, Jun ; Huang, Yi Hui ; Tang, Liping ; Acevedo, Jesus F. ; Word, R. Ann. / Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. In: PLoS One. 2017 ; Vol. 12, No. 10.
@article{9ab1846d816948ba86f072a658aeb255,
title = "Thermosensitive hydrogels deliver bioactive protein to the vaginal wall",
abstract = "The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the ½ life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.",
author = "Good, {Meadow M.} and Montoya, {T. Ignacio} and Haolin Shi and Jun Zhou and Huang, {Yi Hui} and Liping Tang and Acevedo, {Jesus F.} and Word, {R. Ann}",
year = "2017",
month = "10",
day = "1",
doi = "10.1371/journal.pone.0186268",
language = "English (US)",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Thermosensitive hydrogels deliver bioactive protein to the vaginal wall

AU - Good, Meadow M.

AU - Montoya, T. Ignacio

AU - Shi, Haolin

AU - Zhou, Jun

AU - Huang, Yi Hui

AU - Tang, Liping

AU - Acevedo, Jesus F.

AU - Word, R. Ann

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the ½ life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.

AB - The pathophysiology and natural history of pelvic organ prolapse (POP) are poorly understood. Consequently, our approaches to treatment of POP are limited. Alterations in the extracellular matrix components of pelvic support ligaments and vaginal tissue, including collagen and elastin, have been associated with the development of POP in animals and women. Prior studies have shown the protease MMP-9, a key player of ECM degradation, is upregulated in vaginal tissues from both mice and women with POP. On the other hand, fibulin-5, an elastogenic organizer, has been found to inhibit MMP-9 in the vaginal wall. Hence, we hypothesized that prolonged release of fibulin-5 may delay progression of POP. To test the hypothesis, oligo (ethylene glycol)-based thermosensitive hydrogels were fabricated, characterized and then used to deliver fibulin-5 to the vaginal wall and inhibit MMP-9 activity. The results indicate that hydrogels are cell and tissue compatible. The hydrogels also prolong the ½ life of fibulin-5 in cultured vaginal fibroblasts and in the vaginal wall in vivo. Finally, fibulin-5-containing hydrogels resulted in incorporation of fibulin-5 into the vaginal matrix and inhibition of MMP-9 for several weeks after injection. These results support the idea of fibulin-5 releasing hydrogel being developed as a new treatment for POP.

UR - http://www.scopus.com/inward/record.url?scp=85032512892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032512892&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0186268

DO - 10.1371/journal.pone.0186268

M3 - Article

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e0186268

ER -